Raydi,

I would Agree with you. Out of the Million cases stated for misdiagnosed women, Recaf could reduce this way down.

Assuming the sensitivity of Recaf at 93 % for early breast cancers, 930,000 of these 1 million Women would have been diagnosed with cancer correctly.

RECAF(TM)-based test also detected 90% to 93% of Stage I and Stage II (early stage) breast cancer samples, without any false positives.

http://74.125.47.132/search?q=cache:...